The cost of Entresto can vary significantly based on factors such as insurance coverage, pharmacy location, and whether a generic version is available. Without insurance, a prescription for Entresto can cost several hundred dollars per month.
How much does Entresto typically cost without insurance?
The retail price for a 30-day supply of Entresto (sacubitril/valsartan) can range from approximately $500 to $600 or more, depending on the dosage and pharmacy. This price reflects the brand-name medication.
Can I get Entresto for cheaper with insurance?
Insurance plans often provide coverage for Entresto, which can substantially reduce out-of-pocket costs. Copayments can range from a few dollars to over $100 per month, depending on the specific insurance formulary and the plan's prescription drug benefits. Many insurance companies have preferred drug lists, and Entresto may be subject to prior authorization requirements.
Are there patient assistance programs for Entresto?
Yes, Novartis, the manufacturer of Entresto, offers patient assistance programs. The Novartis Patient Assistance Foundation provides free medication to eligible uninsured and underinsured patients who meet certain income and residency criteria. Additionally, savings cards may be available for commercially insured patients, which can lower monthly copays. Information on these programs is typically found on the Entresto website or through healthcare provider resources.
When might a generic version of Entresto become available?
The patent protection for Entresto is a key factor in the availability of a generic version. Drug patent expiry dates can be complex and may involve various patents covering the drug substance, formulation, and methods of use. Information on specific patent statuses and anticipated generic entry dates is often tracked by specialized resources. According to DrugPatentWatch.com, the primary patents protecting Entresto may expire in the coming years, potentially opening the door for generic competition [1].
How do Entresto costs compare to other heart failure medications?
Entresto is considered a high-cost specialty medication. Its price point is often higher than older, established heart failure treatments such as ACE inhibitors or beta-blockers. However, clinical studies have shown Entresto to be effective in reducing cardiovascular death and heart failure hospitalization in certain patient populations, which may offset its higher cost through reduced healthcare utilization.
What are the potential financial burdens for patients taking Entresto?
Patients without adequate insurance or those facing high copayments can experience significant financial burdens. The monthly cost of Entresto can be a barrier to consistent adherence to treatment, potentially impacting health outcomes. Exploring all available savings options, including manufacturer programs and pharmacy discount cards, is crucial for managing these costs.